Autor: "Li Q" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Statistical estimation of fatal and serious injuries saved by iRAP protocols in 74 countries.
Autorzy:: Li Q; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
Bradford J; International Road Assessment Programme, Bracknell, Berkshire, United Kingdom.
Bachani AM; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0301993. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Accidents, Traffic*/prevention & control
Wounds and Injuries*/epidemiology
Wounds and Injuries*/prevention & control
Humans ; Transportation ; Risk Factors ; Interleukin 1 Receptor Antagonist Protein ; Program Evaluation ; Observational Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
Autorzy:: Zhang W; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen L; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Liu J; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen B; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Shi H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Qi H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Wu Z; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Mao X; Department of Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Wang X; Department of Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Huang Y; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Li J; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Yu Z; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Zhong M; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. mkzhong_.
Wang T; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. .
Li Q; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 16; Vol. 43 (1), pp. 114. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Brain Neoplasms*
Neoplastic Syndromes, Hereditary*
Humans ; Microsatellite Instability ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Autophagy-Related Protein 7/genetics ; Immunity ; Cholesterol ; DNA Mismatch Repair
SCR Disease Name:: Turcot syndrome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
Autorzy:: You X; Department of Andrology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518101, Shenzhen, China.
Qiu J; Department of Andrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518033, Shenzhen, China.
Li Q; Department of Andrology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518101, Shenzhen, China.
Zhang Q; Department of Andrology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518101, Shenzhen, China.
Sheng W; School of Rehabilitation Medicine and Health Care, Hunan University of Medicine, 418000, Huaihua, China.; School of Traditional Chinese Medicine, Hunan University of Medicine, 418000, Huaihua, China.
Cao Y; Department of Urology Surgery, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518101, Shenzhen, China. .
Fu W; Department of Andrology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 518101, Shenzhen, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 15; Vol. 24 (1), pp. 472. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Gastrointestinal Microbiome*
Liver Neoplasms*
Prostatic Neoplasms*/drug therapy
Saponins*
Triterpenes*
Male ; Humans ; Animals ; Mice ; Mice, Nude ; Receptor for Advanced Glycation End Products ; Homeostasis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Comparison of early patient-reported outcomes between uniportal thoracoscopic segmentectomy and wedge resection for peripheral small-sized non-small-cell lung cancer.
Autorzy:: Zhao Y; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Liu W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Gao X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zhang K; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Graduate School, Chengdu Medical college, Chengdu, 610041, Sichuan, China.
Dai W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Wei X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zheng H; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Lei C; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.
Yu H; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Shi Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Li Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Xie T; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 15; Vol. 19 (1), pp. 215. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Aftercare ; Neoplasm Staging ; Patient Discharge ; Pneumonectomy/methods ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The effects of psychological distress after surgery in patients undergoing lumbar spinal fusion.
Autorzy:: Li Q; Department of Spine Surgery, Qingdao Municipal Hospital Group, No.5 Donghai Middle Road, Shinan District, Qingdao, 266000, China.
Luan J; Department of Spine Surgery, Qingdao Municipal Hospital Group, No.5 Donghai Middle Road, Shinan District, Qingdao, 266000, China.
Lin Y; Department of Spine Surgery, Qingdao Municipal Hospital Group, No.5 Donghai Middle Road, Shinan District, Qingdao, 266000, China.
Kong M; Department of Spine Surgery, Qingdao Municipal Hospital Group, No.5 Donghai Middle Road, Shinan District, Qingdao, 266000, China.
Guo X; Department of Orthopaedics, Peking University Third Hospital, No.49 North Garden Road, Haidian District, Beijing, 100191, China. .
Zhao J; Department of Spine Surgery, Qingdao Municipal Hospital Group, No.5 Donghai Middle Road, Shinan District, Qingdao, 266000, China. .; Pokaż więcej
Źródło:: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Apr 13; Vol. 25 (1), pp. 289. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:: Journal Article
MeSH Terms:: Spinal Fusion*/adverse effects
Psychological Distress*
Humans ; Lumbosacral Region ; Neurosurgical Procedures ; Pain

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Study of association of leptin with leukocyte telomere length in a Chinese rural population.
Autorzy:: Li J; Public Health School, Ningxia Medical University, Yinchuan, 750004, China.
Yang C; School of Nursing, Ningxia Medical University, Yinchuan, Ningxia, China.
Zhang Y; Public Health School, Ningxia Medical University, Yinchuan, 750004, China.
Li Q; Public Health School, Ningxia Medical University, Yinchuan, 750004, China.
Liu X; Public Health School, Ningxia Medical University, Yinchuan, 750004, China.
Zhang Y; Public Health School, Ningxia Medical University, Yinchuan, 750004, China. .; NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, 750004, China. .; Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, China. .
Zhao Y; Public Health School, Ningxia Medical University, Yinchuan, 750004, China. .; NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, 750004, China. .; Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, China. .; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2024 Apr 13; Vol. 23 (1), pp. 103. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:: Journal Article
MeSH Terms:: Leptin*/genetics
Insulin Resistance*/genetics
Female ; Male ; Humans ; Cohort Studies ; Rural Population ; Telomere Shortening ; Telomere/genetics ; Adipokines ; China ; Leukocytes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The polymorphism analysis for CD36 among platelet donors.
Autorzy:: Lyu Q; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, Sichuan, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, 610052, Sichuan, China.
Lin Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, Sichuan, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, 610052, Sichuan, China.; School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Pan Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, Sichuan, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, 610052, Sichuan, China.
Guan X; Department of Blood Transfusion, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
Ji X; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, Sichuan, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, 610052, Sichuan, China.
Peng M; Yunnan Kunming Blood Center, Kunming, 650000, Yunnan, China.
Li Q; Yunnan Kunming Blood Center, Kunming, 650000, Yunnan, China.
Wang Z; Yunnan Kunming Blood Center, Kunming, 650000, Yunnan, China.
Zhang Z; Yunnan Kunming Blood Center, Kunming, 650000, Yunnan, China.
Luo Z; Yunnan Kunming Blood Center, Kunming, 650000, Yunnan, China. .
Su P; Department of Transfusion Medicine, Affiliated Hospital of Yunnan University, Kunming, 650000, Yunnan, China. .
Wang J; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, Sichuan, China. .; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, 610052, Sichuan, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 12; Vol. 14 (1), pp. 8534. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:: Journal Article
MeSH Terms:: CD36 Antigens*/genetics
Blood Platelet Disorders*
Humans ; Blood Platelets ; Databases, Factual ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: MiR-132-3p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting TGF-β1/Smad2/3 signaling pathway.
Autorzy:: Yin Y; School of Medicine, Guizhou University, Guiyang, Guizhou, China.; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Yang Y; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Zhang Y; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Shang Y; Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Li Q; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Yuan J; School of Medicine, Guizhou University, Guiyang, Guizhou, China.; Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 11; Vol. 19 (4), pp. e0301540. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Peritoneal Fibrosis*/genetics
Peritoneal Fibrosis*/chemically induced
Peritoneal Dialysis*/adverse effects
MicroRNAs*/genetics
Rats ; Humans ; Animals ; Transforming Growth Factor beta1/metabolism ; Rats, Sprague-Dawley ; Chlorhexidine/therapeutic use ; Losartan/therapeutic use ; Signal Transduction ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.
Autorzy:: Guo Y; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Wang Z; The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Zhou H; The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Han W; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Deng Y; Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong, China.
Li Q; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Xue J; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Ge X; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Wang S; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Wang J; Translational Science, GenFleet Therapeutics Inc, Shanghai, China.
Zhang Y; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Zhao C; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Zhu H; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Wang Y; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Shen H; Clinical Department, GenFleet Therapeutics Inc, Shanghai, China.
Liu D; Translational Science, GenFleet Therapeutics Inc, Shanghai, China.
Li J; Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 10; Vol. 24 (1), pp. 444. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Neoplasms*/drug therapy
Neoplasms*/pathology
Receptors, Transforming Growth Factor beta*/antagonists & inhibitors
Adult ; Humans ; Response Evaluation Criteria in Solid Tumors ; Transforming Growth Factor beta

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer.
Autorzy:: Gamallat Y; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Felipe Lima J; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Seyedi S; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Li Q; Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.
Rokne JG; Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.
Alhajj R; Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.; Department of Computer Engineering, Istanbul Medipol University, 34810 Istanbul, Turkey.; Department of Health Informatics, University of Southern Denmark, 5230 Odense, Denmark.
Ghosh S; Department of Medical Oncology, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R7, Canada.; Department of Public Health Sciences, Henry Ford Health, Detroit, MI 48202, USA.
Bismar TA; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Tom Baker Cancer Center, Alberta Health Services, Calgary, AB T2N 4N1, Canada.; Prostate Cancer Centre, Alberta Health Services, Calgary, AB T2V 1P9, Canada.; Department of Pathology, Alberta Precision Labs, Calgary, AB T2V 1P9, Canada.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2024 Apr 08; Vol. 16 (7). Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Autorzy:: Wang H; Department of Nuclear Medicine, West China Hospital, Sichuan University, No 37. Guoxue Alley, 610041, Chengdu, China.
Zhang C; West China Biomedical Big Data Center, West China Hospital, Sichuan University, 610041, Chengdu, China.
Li Q; Department of Nuclear Medicine, West China Hospital, Sichuan University, No 37. Guoxue Alley, 610041, Chengdu, China.
Tian T; Department of Nuclear Medicine, West China Hospital, Sichuan University, No 37. Guoxue Alley, 610041, Chengdu, China.
Huang R; Department of Nuclear Medicine, West China Hospital, Sichuan University, No 37. Guoxue Alley, 610041, Chengdu, China.
Qiu J; West China Biomedical Big Data Center, West China Hospital, Sichuan University, 610041, Chengdu, China. .
Tian R; Department of Nuclear Medicine, West China Hospital, Sichuan University, No 37. Guoxue Alley, 610041, Chengdu, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 427. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Iodine Radioisotopes*
Thyroid Neoplasms*/epidemiology
Thyroid Neoplasms*/surgery
Humans ; Thyroid Cancer, Papillary ; Neoplasm Recurrence, Local/epidemiology ; Machine Learning ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Metabolic Characteristics and Discriminative Diagnosis of Growth Hormone Deficiency and Idiopathic Short Stature in Preadolescents and Adolescents.
Autorzy:: Chang Y; Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
Chen J; Department of Child Health, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361003, China.
Zhu H; Education Section and Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
Huang R; Department of Child Health, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361003, China.
Wu J; Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
Lin Y; Department of Child Health, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361003, China.
Li Q; Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
Shen G; Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
Feng J; Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Apr 07; Vol. 29 (7). Date of Electronic Publication: 2024 Apr 07.
Typ publikacji:: Journal Article
MeSH Terms:: Phosphorylcholine*
Dwarfism*/diagnosis
Adolescent ; Humans ; Lipid Metabolism ; Biomarkers ; Growth Hormone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC.
Autorzy:: Chan YT; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Wu J; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Lu Y; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Li Q; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Feng Z; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Xu L; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Yuan H; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Xing T; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Zhang C; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Tan HY; Centre for Chinese Medicine New Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
Feng Y; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Wang N; School of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Apr 06; Vol. 23 (1), pp. 74. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
RNA, Long Noncoding*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Humans ; Mice ; Animals ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; RNA, Guide, CRISPR-Cas Systems ; PPAR alpha/genetics ; PPAR alpha/metabolism ; PPAR alpha/therapeutic use ; Proteomics ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Triel Bonds between BH 3 /C 5 H 4 BX and M(MDA) 2 (X = H, CN, F, CH 3 , NH 2 ; M = Ni, Pd, Pt, MDA = Enolated Malondialdehyde) and Group 10 Transition Metal Electron Donors.
Autorzy:: Wang X; The Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.
Niu Z; The Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.
McDowell SAC; Department of Biological and Chemical Sciences, The University of the West Indies, Cave Hill Campus, Bridgetown BB11000, Barbados.
Li Q; The Laboratory of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Apr 03; Vol. 29 (7). Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response.
Autorzy:: Qin Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Zhou Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Guo J; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Chen Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.
Tang W; Department of Medical Oncology, School of Medicine, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen University, Xiamen, 361003, China.; Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, The School of Clinical Medicine of Fujian, Medical University, Xiamen, 361003, China.
Li Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
You J; Department of Gastrointestinal Oncology Surgery, The First Affiliated Hospital of Xiamen University, Cancer Center, Xiamen, 361003, China.
Li Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China. qiyuan.li@xmu.edu.cn.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China. qiyuan.li@xmu.edu.cn.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China. qiyuan.li@xmu.edu.cn.; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 47. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: DNA Methylation*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Epigenesis, Genetic ; Tumor Microenvironment/genetics ; Gene Expression Profiling/methods ; Prognosis ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
Autorzy:: Yang Y; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Huang L; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Zhang N; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Deng YN; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Cao X; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Liang Y; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Hou H; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Luo Y; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China.
Yang Y; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Liang S; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, 3rd Section of People's South Road, Chengdu, 610041, People's Republic of China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Apr 02; Vol. 22 (1), pp. 206. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Animals ; Humans ; Mice ; Annexin A6/genetics ; Annexin A6/metabolism ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Chromatography, Liquid ; Epithelial-Mesenchymal Transition/genetics ; Gene Expression Regulation, Neoplastic ; Proto-Oncogene Proteins c-akt/metabolism ; rho GTP-Binding Proteins/metabolism ; Sumoylation ; Tandem Mass Spectrometry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Intranasal delivery of phenytoin loaded layered double hydroxide nanoparticles improves therapeutic effect on epileptic seizures.
Autorzy:: Zhang J; Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Zuo H; The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Fu Y; Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Cao Y; Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Li Q; Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Zhang Q; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Zheng Y; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Wang Y; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Wu D; Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Chen W; Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China. .
Fang J; Department of Neurology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 02; Vol. 22 (1), pp. 144. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Epilepsy*/drug therapy
Nanoparticles*/therapeutic use
Mice ; Animals ; Phenytoin/pharmacology ; Phenytoin/therapeutic use ; Administration, Intranasal ; Tissue Distribution ; Seizures/drug therapy ; Hydroxides/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Triglyceride to high-density lipoprotein cholesterol ratio associated with long-term adverse clinical outcomes in patients deferred revascularization following fractional flow reserve.
Autorzy:: Li F; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Li X; Department of Digestive Oncology, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030032, China.
Zhou J; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Lin Q; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Zhou Y; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Zhu J; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Wu K; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Zhao D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Li Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Wang H; Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, 030001, China. .
Liu Q; Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, 410000, China. .; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2024 Apr 02; Vol. 23 (1), pp. 96. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Fractional Flow Reserve, Myocardial*
Coronary Artery Disease*/surgery
Humans ; Retrospective Studies ; Cholesterol, HDL ; Triglycerides ; Coronary Angiography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Regulatory mechanisms of autophagy on DHA and carotenoid accumulation in Crypthecodinium sp. SUN.
Autorzy:: Li Y; Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Collaborative Innovation Center for Eco-Environment, Hebei Research Center of the Basic Discipline of Cell Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, 050024, China.; School of Life Sciences, Hebei University, Baoding, 071000, China.
Zhao T; Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Collaborative Innovation Center for Eco-Environment, Hebei Research Center of the Basic Discipline of Cell Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, 050024, China.
Gao W; School of Life Sciences, Hebei University, Baoding, 071000, China.
Miao B; School of Life Sciences, Hebei University, Baoding, 071000, China.
Fu Z; School of Life Sciences, Hebei University, Baoding, 071000, China.
Zhang Z; School of Life Sciences, Hebei University, Baoding, 071000, China.
Li Q; Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Collaborative Innovation Center for Eco-Environment, Hebei Research Center of the Basic Discipline of Cell Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, 050024, China. .
Sun D; Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Collaborative Innovation Center for Eco-Environment, Hebei Research Center of the Basic Discipline of Cell Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, 050024, China. .; Pokaż więcej
Źródło:: Biotechnology for biofuels and bioproducts [Biotechnol Biofuels Bioprod] 2024 Apr 02; Vol. 17 (1), pp. 50. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension.
Autorzy:: Zhang X; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.; China Academy of Chinese Medical Sciences, Beijing, China.
Wei R; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Wang X; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.; China Academy of Chinese Medical Sciences, Beijing, China.
Zhang W; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Li M; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.; China Academy of Chinese Medical Sciences, Beijing, China.
Ni T; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Weng W; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. .; National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1, Xiyuan Playground, Zhong Zhi Road, Hai Dian District, Beijing, 100091, China. .
Li Q; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. .; Department of General Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1, Xiyuan Playground, Zhong Zhi Road, Hai Dian District, Beijing, 100091, China. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Apr 02; Vol. 23 (1), pp. 117. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Hypertension*/diagnosis
Cardiovascular System*
Adult ; Humans ; Neutrophils ; Nutrition Surveys ; Lymphocytes ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Li Q"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język